Old Web
English
Sign In
Acemap
>
Paper
>
Efficacy and safety of eribulin in various subtypes of breast cancer: data from real clinical practice in Russia
Efficacy and safety of eribulin in various subtypes of breast cancer: data from real clinical practice in Russia
2017
Ludmila Manzyuk
Elena Kovalenko
Vera Gorbunova
L.V. Bolotina
Tatiana Semiglazova
Larisa Zhilyaeva
Y. A. Mishina
Dmitry Ponomarenko
V. E. Goldberg
N Popova
Elena Karabina
Guzel Zinurovna Mukhametshina
Alfia Khasanova
Sufia Safina
M. V. Shaidorov
Liubov Yu Vladimirova
I. S. Mitashok
E. P. Prokofieva
Irina Vladimirovna Evstigneeva
I. I. Andreyashkina
Natalya A Abramova
Irina L. Popova
A. A. Teterich
E. A. Gaisina
V. A. Chubenko
S. V. Limareva
Natalya Mikhailovna Tikhanovskaya
Anna E Storozhakova
N. Y. Samaneva
Ya. V. Svetitskaya
Tatyana A. Snezhko
E. A. Kalabanova
A. Y. Povyshev
I. V. Yudina
L. V. Vorotilina
T. V. Andreeva
G. C. Tumanyan
A.E. Kozyakov
L. A. Gilmutdinova
Keywords:
Breast cancer
Clinical Practice
Eribulin
Internal medicine
Pathology
Oncology
Medicine
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]